Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

NCT00476073 is registered in ClinicalTrials.gov with Mundipharma Research Limited as lead sponsor.

NCT NCT00476073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00476073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma
Lead sponsor
Mundipharma Research Limited
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
January 31, 2008
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma bronchiale